Measuring market orientation of Muscle Pharm Corp. (MSLP:US) British American Tobacco South Africa | Page 3

British American Tobacco South Africa: Evaluating the role and substance of its strategy in achieving sustainable competitive advantage

Table of contents

1.

Introduction – Company Overview ............................................................................................... 4

1.1. Understanding the tobacco business & value creation channel in South Africa ............................... 5
2.

Enterprise Strategy - Business Strategy Analysis ...................................................................... 6
2.1

Strategic Imperatives ............................................................................................................... 7

2.2

Value Chain Analysis of BATSA – Potentially a monopoly ....................................................... 8

2.3

Sustainable competitive advantage – Economic Moat ............................................................. 8

2.4

Key performance indicators (KPI) and track record.................................................................. 9

2.5

Analysis of SWOT .................................................................................................................. 10

2.5.1 Challenges and strategic reaction for future prospects .......................................................... 11
3.

Enablers and constraints of strategic model and methodology used..................................... 12
3.1

The new St. Galler Management Model as an alternative tool in strategic analysis ............... 13

4.

Recommendations for strategic future of enterprise ................................................................ 14

5.

Conclusion ................................................................................................................................... 15

6.

Appendix – Factsheet British American Tobacco PLC ............................................................. 16

7.

Bibliography ................................................................................................................................. 17